Flora Growth Corp
For the period ended Dec 31, 2023. Filed Mar 28, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 28, 2024
ZSTK$2.69+6.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Changes in Shareholders' Equity
Consolidated Statement of Shareholders' Equity
(in thousands of United States dollars, except share amounts which are in thousands of shares)
| Common Shares · Additionalpaid-incapital · Accumulated othercomprehensive(loss) income · AccumulatedDeficit · Non-Controllinginterests insubsidiaries(Deficiency) · Shareholders'Equity | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| # | |||||||||
| Balance, December 31, 2021 | 3,276 | - | 116,810 | (1,108) | (38,536) | (225) | 76,941 | ||
| December unit offering | 625 | - | 5,000 | - | - | - | 5,000 | ||
| December unit offering issuance costs | - | - | (415) | - | - | - | (415) | ||
| Share repurchase | (18) | - | (255) | - | - | - | (255) | ||
| Common shares issued for business combinations | 2,651 | - | 24,492 | - | - | - | 24,492 | ||
| Equity issued for other agreements | 40 | - | 1,554 | - | - | - | 1,554 | ||
| Acquisition of noncontrolling interest | 6 | - | 283 | - | (365) | 28 | (54) | ||
| Options issued | - | - | 4,003 | - | - | - | 4,003 | ||
| Options exercised | 27 | - | 82 | - | - | - | 82 | ||
| Options expired/cancelled | - | - | (1,580) | - | 451 | - | (1,129) | ||
| Restricted stock vesting | 146 | - | 446 | - | - | - | 446 | ||
| Warrants exercised | 23 | - | 105 | - | - | - | 105 | ||
| Warrants expired/cancelled | - | - | - | - | - | - | - | ||
| Share issuance costs | - | - | (105) | - | - | - | (105) | ||
| Other comprehensive loss -exchange differences on foreign operations (net of income taxes of $nil) | - | - | - | (1,624) | - | - | (1,624) | ||
| Current year net loss attributable to Flora | - | - | - | - | (52,415) | (214) | (52,629) | ||
| Balance, December 31, 2022 | 6,776 | $ | - | $150,420 | $(2,732) | $(90,865) | $(411) | $56,412 | |
| September unit offering | 1,369 | - | 2,738 | - | - | - | 2,738 | ||
| September unit offering issuance costs | - | - | (254) | - | - | - | (254) | ||
| Equity issued for other agreements | 126 | - | 590 | - | - | - | 590 | ||
| Options issued | - | - | 226 | - | - | - | 226 | ||
| Options forfeited | - | - | (5,627) | - | 5,352 | - | (275) | ||
| Restricted stock granted | 838 | - | 1,989 | - | - | - | 1,989 | ||
| Restricted stock cancelled | (174) | - | (844) | - | - | - | (844) | ||
| Share issuance costs | - | - | (145) | - | - | - | (145) | ||
| Derecognition of equity related to Colombia assets | - | - | - | 1,310 | - | (278) | 1,032 | ||
| Other comprehensive loss -exchange differences on foreign operations (net of income taxes of $nil) | - | - | - | 1,282 | - | - | 1,282 | ||
| Current year net loss attributable to Flora | - | - | - | - | (57,036) | 689 | (56,347) | ||
| Balance, December 31, 2023 | 8,935 | $ | - | $149,093 | $(140) | $(142,549) | $ | - | $6,404 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.